These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15121766)

  • 21. The myogenic regulatory circuit that controls cardiac/slow twitch troponin C gene transcription in skeletal muscle involves E-box, MEF-2, and MEF-3 motifs.
    Christensen TH; Kedes L
    Gene Expr; 1999; 8(4):247-61. PubMed ID: 10794526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis.
    Lilly B; Galewsky S; Firulli AB; Schulz RA; Olson EN
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5662-6. PubMed ID: 8202544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors.
    Molkentin JD; Olson EN
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9366-73. PubMed ID: 8790335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.
    Black BL; Olson EN
    Annu Rev Cell Dev Biol; 1998; 14():167-96. PubMed ID: 9891782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle.
    McGee SL; Sparling D; Olson AL; Hargreaves M
    FASEB J; 2006 Feb; 20(2):348-9. PubMed ID: 16368714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase.
    Holmes BF; Sparling DP; Olson AL; Winder WW; Dohm GL
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1071-6. PubMed ID: 16105857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2.
    Han A; Pan F; Stroud JC; Youn HD; Liu JO; Chen L
    Nature; 2003 Apr; 422(6933):730-4. PubMed ID: 12700764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AVP induces myogenesis through the transcriptional activation of the myocyte enhancer factor 2.
    Scicchitano BM; Spath L; Musarò A; Molinaro M; Adamo S; Nervi C
    Mol Endocrinol; 2002 Jun; 16(6):1407-16. PubMed ID: 12040025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.
    Quinn ZA; Yang CC; Wrana JL; McDermott JC
    Nucleic Acids Res; 2001 Feb; 29(3):732-42. PubMed ID: 11160896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocyte-specific enhancer factor 2 acts cooperatively with a muscle activator region to regulate Drosophila tropomyosin gene muscle expression.
    Lin MH; Nguyen HT; Dybala C; Storti RV
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4623-8. PubMed ID: 8643453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis.
    Okamoto S; Li Z; Ju C; Scholzke MN; Mathews E; Cui J; Salvesen GS; Bossy-Wetzel E; Lipton SA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3974-9. PubMed ID: 11904443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genomic revolution for cardiovascular disease-a progress report at five years.
    Stewart AF; Roberts R
    Am Heart Hosp J; 2011; 9(1):E19-23. PubMed ID: 21823071
    [No Abstract]   [Full Text] [Related]  

  • 33. Activation of Xenopus MyoD transcription by members of the MEF2 protein family.
    Wong MW; Pisegna M; Lu MF; Leibham D; Perry M
    Dev Biol; 1994 Dec; 166(2):683-95. PubMed ID: 7813786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structures and chromosome locations of the human MEF2A gene and a pseudogene MEF2AP.
    Suzuki E; Lowry J; Sonoda G; Testa JR; Walsh K
    Cytogenet Cell Genet; 1996; 73(3):244-9. PubMed ID: 8697817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-mef2 is a target for Tinman activation during Drosophila heart development.
    Gajewski K; Kim Y; Lee YM; Olson EN; Schulz RA
    EMBO J; 1997 Feb; 16(3):515-22. PubMed ID: 9034334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.
    Choi SJ; Park SY; Han TH
    Nucleic Acids Res; 2001 Jul; 29(13):2836-42. PubMed ID: 11433030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription of the myogenic regulatory gene Mef2 in cardiac, somatic, and visceral muscle cell lineages is regulated by a Tinman-dependent core enhancer.
    Cripps RM; Zhao B; Olson EN
    Dev Biol; 1999 Nov; 215(2):420-30. PubMed ID: 10545248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of CVD in 2015: Using genomic approaches to identify CVD-causing variants.
    Arnett DK
    Nat Rev Cardiol; 2016 Feb; 13(2):72-4. PubMed ID: 26763539
    [No Abstract]   [Full Text] [Related]  

  • 39. D-mef2: a Drosophila mesoderm-specific MADS box-containing gene with a biphasic expression profile during embryogenesis.
    Nguyen HT; Bodmer R; Abmayr SM; McDermott JC; Spoerel NA
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7520-4. PubMed ID: 8052612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex.
    Leifer D; Krainc D; Yu YT; McDermott J; Breitbart RE; Heng J; Neve RL; Kosofsky B; Nadal-Ginard B; Lipton SA
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1546-50. PubMed ID: 7679508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.